N-[4-[(3R)-3-aminopiperidin-1-yl]-3-bromo-7H-cyclopenta[b]pyridin-5-yl]-1-benzylpyrazole-4-carboxamide
C24H25BrN6O — CID 158143436
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[(3R)-3-aminopiperidin-1-yl]-3-bromo-7H-cyclopenta[b]pyridin-5-yl]-1-benzylpyrazole-4-carboxamide
N-[4-[(3R)-3-aminopiperidin-1-yl]-3-bromo-7H-cyclopenta[b]pyridin-5-yl]-1-benzylpyrazole-4-carboxamide (PubChem CID 158143436) has the molecular formula C24H25BrN6O and a molecular weight of 493.41 g/mol. Its IUPAC name is N-[4-[(3R)-3-aminopiperidin-1-yl]-3-bromo-7H-cyclopenta[b]pyridin-5-yl]-1-benzylpyrazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[4-[(3R)-3-aminopiperidin-1-yl]-3-bromo-7H-cyclopenta[b]pyridin-5-yl]-1-benzylpyrazole-4-carboxamide |
|---|---|
| PubChem CID | 158143436 |
| Molecular Formula | C24H25BrN6O |
| Molecular Weight | 493.41 g/mol |
| Exact Mass | 492.13 |
| IUPAC Name | N-[4-[(3R)-3-aminopiperidin-1-yl]-3-bromo-7H-cyclopenta[b]pyridin-5-yl]-1-benzylpyrazole-4-carboxamide |
| SMILES | N[C@@H]1CCCN(c2c(Br)cnc3c2C(NC(=O)c2cnn(Cc4ccccc4)c2)=CC3)C1 |
| InChI | InChI=1S/C24H25BrN6O/c25-19-12-27-20-8-9-21(22(20)23(19)30-10-4-7-18(26)15-30)29-24(32)17-11-28-31(14-17)13-16-5-2-1-3-6-16/h1-3,5-6,9,11-12,14,18H,4,7-8,10,13,15,26H2,(H,29,32)/t18-/m1/s1 |
| InChIKey | TWGQBWOYEIWJQF-GOSISDBHSA-N |
| XLogP | 3.34 |
| TPSA | 89.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 493.41 |
| LogP ≤ 5 | 3.34 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158143436 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.